The loop diuretics market is projected to grow with a CAGR of ~7% during the forecast period, i.e., 2022-2030 on account of the increasing prevalence of hypertension and chronic diseases, and growing incidences of lifestyle related diseases. Furthermore, advancements in technology and growing cases of renal diseases are also anticipated to drive market growth in the forthcoming years.
Research Nester released a report titled “Loop Diuretics Market: Global Demand Analysis & Opportunity Outlook 2030″ which delivers detailed overview of the global loop diuretics market in terms of market segmentation by indication, drugs, route of administration, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The market is segmented based on application into diabetes insipidus, edema, hypercalciuria, hypertension and, others, out of which, the hypertension segment is anticipated to grab the largest share by the end of 2029, which can be credited to the increasing prevalence of high blood pressure and trend of sedentary lifestyle among the global population.
Request Sample For More Information@ https://www.researchnester.com/sample-request-3137
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the loop diuretics market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period owing to the increasing pollution and occurrence of chronic diseases. Currently, the market in North America holds the largest share, which can be attributed to the presence of leading healthcare providers in the region, especially in the United States, and growing lifestyles changes in the region.
Increasing Prevalence of Chronic Diseases to Drive the Market Growth
The prevalence of chronic diseases is on a global rise since the last few decades. Disorders related to kidney problems and high blood pressure such as hypertension and chronic obstructive pulmonary disease (COPD) are growing at a fast pace, which in turn is estimated to heighten the demand for loop diuretic drugs in the near future.
However, side effects regarding loop diuretics drugs are expected to hinder growth of the market during the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global loop diuretics market which includes company profiling of Pfizer Inc., Merck & Co., Meda Manufacturing GmbH, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Cipla Ltd, Endo International plc, Hikma Pharmaceuticals Inc., Teva Pharmaceuticals Industries Ltd, Novartis AG, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global loop diuretics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Purchase Copy of this Report@https://www.researchnester.com/purchage/purchase_product.php?token=3137
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
For more information, please contact: